Seda welcomes new CEO from Big Pharma
Published on 17/04/2019
Today we welcome our new CEO, Prof Paul W Stott to Seda. Paul joins us from his previous role as VP, Global Product Development at AstraZeneca at a time when we are about to embark on a significant period of growth. We are progressing well with our new laboratory and office complex at Alderley Park and are in the process of equipping the facility to meet the needs of our client base. Our roster of talent continues to grow with appointments at all levels of the organisation with more to come.
Dr Paul Dickinson, Director and Co-Founder, states ‘Paul S brings a wealth of experience to the team having performed several senior executive roles in big pharma and overseeing the approval and launch of numerous blockbuster medicines. His appointment complements the existing talents at Seda and is a demonstration of our growing presence and ambition.’